A concomitant improved relapse free survival in breast cancer patients with increased expression of POMT2 (Fig. 7C), PMEPA1 (Fig. 7D) and SUMF1 (Fig. 7F) indicated their tumor suppressive behavior. Here, SUMF1 is linked to breast carcinoma.